These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 37050929)

  • 1. Familial Hypertrophic Cardiomyopathy: Diagnosis and Management.
    Litt MJ; Ali A; Reza N
    Vasc Health Risk Manag; 2023; 19():211-221. PubMed ID: 37050929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypertrophic cardiomyopathy.
    Enriquez AD; Goldman ME
    Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic counseling and testing for hypertrophic cardiomyopathy: an adult perspective.
    Skrzynia C; Demo EM; Baxter SM
    J Cardiovasc Transl Res; 2009 Dec; 2(4):493-9. PubMed ID: 20560007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new era in clinical genetic testing for hypertrophic cardiomyopathy.
    Wheeler M; Pavlovic A; DeGoma E; Salisbury H; Brown C; Ashley EA
    J Cardiovasc Transl Res; 2009 Dec; 2(4):381-91. PubMed ID: 20559996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic counseling and testing for hypertrophic cardiomyopathy: the pediatric perspective.
    Demo EM; Skrzynia C; Baxter S
    J Cardiovasc Transl Res; 2009 Dec; 2(4):500-7. PubMed ID: 20560008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnosis and treatment of hypertrophic cardiomyopathy.
    Prinz C; Farr M; Hering D; Horstkotte D; Faber L
    Dtsch Arztebl Int; 2011 Apr; 108(13):209-15. PubMed ID: 21505608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current perspectives in hypertrophic cardiomyopathy with the focus on patients in the Finnish population: a review.
    Kuusisto J; Sipola P; Jääskeläinen P; Naukkarinen A
    Ann Med; 2016 Nov; 48(7):496-508. PubMed ID: 27460395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant form of familial hypertrophic cardiomyopathy complicated with ventricular fibrillation in siblings. Electrocardiogram in hypertrophic cardiomyopathy - a review].
    Kukla P; Petkow-Dimitrow P; Jastrzebski M; Bednarek J; Lelakowski J; Bryniarski L
    Kardiol Pol; 2009 Jul; 67(7):774-80; discussion 781. PubMed ID: 19650001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: a review.
    Hensley N; Dietrich J; Nyhan D; Mitter N; Yee MS; Brady M
    Anesth Analg; 2015 Mar; 120(3):554-569. PubMed ID: 25695573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic impact of genetic testing in hypertrophic cardiomyopathy: The story of two families.
    Lorca R; Martín M; Gómez J; Junquera MR; Morís C; Coto E; Reguero JJR
    Int J Cardiol; 2016 Feb; 205():161-162. PubMed ID: 26736093
    [No Abstract]   [Full Text] [Related]  

  • 12. Is Hypertrophic Cardiomyopathy Always a Familial and Inherited Disease?
    Bonaventura J; Rowin EJ; Maron MS; Maron BJ
    J Am Heart Assoc; 2023 Jun; 12(12):e028974. PubMed ID: 37301765
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical characteristics of hypertrophic cardiomyopathy in children: An 8-year single center experience.
    Tunca Sahin G; Ozgur S; Kafali HC; Sevinc Sengul F; Haydin S; Guzeltas A; Ergul Y
    Pediatr Int; 2021 Jan; 63(1):37-45. PubMed ID: 32682351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstructive hypertrophic cardiomyopathy: a review of new therapies.
    Mehra N; Ali AH; Desai MY
    Future Cardiol; 2023 Oct; 19(13):661-670. PubMed ID: 37933625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine.
    Maron BJ; Ommen SR; Semsarian C; Spirito P; Olivotto I; Maron MS
    J Am Coll Cardiol; 2014 Jul; 64(1):83-99. PubMed ID: 24998133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators.
    Maron BJ; Casey SA; Olivotto I; Sherrid MV; Semsarian C; Autore C; Ahmed A; Boriani G; Francia P; Winters SL; Giudici M; Koulova A; Garberich R; Rowin EJ; Sears SF; Maron MS; Spirito P
    Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e005820. PubMed ID: 29625970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy considerations for the managed care pharmacist.
    Taddei-Allen P
    Am J Manag Care; 2021 Apr; 27(6 Suppl):S118-S125. PubMed ID: 33861536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving Strategies for the Management of Obstructive Hypertrophic Cardiomyopathy.
    Liang LW; Lumish HS; Sewanan LR; Shimada YJ; Maurer MS; Weiner SD; Clerkin KJ
    J Card Fail; 2024 Sep; 30(9):1136-1153. PubMed ID: 38777216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current and emerging perspectives on pathophysiology, diagnosis, and management of hypertrophic cardiomyopathy.
    Gartzonikas IK; Naka KK; Anastasakis A
    Hellenic J Cardiol; 2023; 70():65-74. PubMed ID: 36403865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Living with hypertrophic cardiomyopathy: a patient's perspective.
    Borsari W; Davis L; Meiers E; Salberg L; Barbara McDonough
    Future Cardiol; 2022 Jan; 18(1):43-50. PubMed ID: 34533409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.